高速分拣大细胞的泵
|
By LabMedica International staff writers Posted on 25 Aug 2017 |

图片:微流控芯片能够以16微秒的高速分拣细胞。放大视图展示了片上分拣小眼虫细胞(图片蒙名古屋大学惠赐)。
许多医疗应用场合必须分拣单个细胞,包括从细胞悬液中分离特定的细胞类型。科研人员已经用荧光活化细胞分拣(FACS)做高通量细胞分拣。
较大细胞的FACS要求在低压下处理样本,让样本通过更宽的喷嘴,以防止损坏,因此分拣受限于低水平通量。用激光激励液滴中细胞的自体荧光或标记荧光,然后使液滴发生偏转,按照不同特性进入不同容器。因为产生的喷雾剂导致样本感染,所以这项技术引人担忧。
日本名古屋大学的科学家研究细胞分拣时用一颗微流控芯片预防样本感染。这颗芯片有微通道,将细胞悬液导入微通道进行分拣。科研小组在微流控芯片里集成了两只外部驱动的片上泵,以实现高速的流控制。他们用一只高速发动器作为泵的动力源,成功生成了一股持续16微秒的液流,进行细胞分拣。
虽然提出了各种片上细胞分拣方法,但是大细胞的高通量分拣仍受制于在大范围分拣区内控制高速液流的困难。为克服这一难题,科研小组提出把压电发动器放在微流控芯片外,用它驱动双膜泵,实现高速的局部流控制。他们评估了把液流特征换成局部流的可控性。
他们用这项技术不仅能分拣大细胞,还能分拣小细胞,而且速度快,纯度高,活力强。以100微米左右的微藻类为例测试该方法,得到95.8%的纯度、90.8%的存活率和92.8%的成功率。他们用24微米左右的癌细胞作为小细胞的模型,得到了98.9%的纯度、90.7%的存活率和97.8%的成功率。
该研究的论文发表于2017年6月14日的《芯片实验室》杂志。领衔作者、助理教授Shinya Sakuma博士说:“微流控芯片拥有十字形分拣区和有三个分支的微流控通道。主通道里的靶体/非靶体细胞在三个维度上对齐。当检测到靶细胞时,片上泵迅速启动,把细胞拣入两条兴趣通道之一。同时,把非靶细胞冲入废料通道,泵不发动。
Related Links:
名古屋大学
较大细胞的FACS要求在低压下处理样本,让样本通过更宽的喷嘴,以防止损坏,因此分拣受限于低水平通量。用激光激励液滴中细胞的自体荧光或标记荧光,然后使液滴发生偏转,按照不同特性进入不同容器。因为产生的喷雾剂导致样本感染,所以这项技术引人担忧。
日本名古屋大学的科学家研究细胞分拣时用一颗微流控芯片预防样本感染。这颗芯片有微通道,将细胞悬液导入微通道进行分拣。科研小组在微流控芯片里集成了两只外部驱动的片上泵,以实现高速的流控制。他们用一只高速发动器作为泵的动力源,成功生成了一股持续16微秒的液流,进行细胞分拣。
虽然提出了各种片上细胞分拣方法,但是大细胞的高通量分拣仍受制于在大范围分拣区内控制高速液流的困难。为克服这一难题,科研小组提出把压电发动器放在微流控芯片外,用它驱动双膜泵,实现高速的局部流控制。他们评估了把液流特征换成局部流的可控性。
他们用这项技术不仅能分拣大细胞,还能分拣小细胞,而且速度快,纯度高,活力强。以100微米左右的微藻类为例测试该方法,得到95.8%的纯度、90.8%的存活率和92.8%的成功率。他们用24微米左右的癌细胞作为小细胞的模型,得到了98.9%的纯度、90.7%的存活率和97.8%的成功率。
该研究的论文发表于2017年6月14日的《芯片实验室》杂志。领衔作者、助理教授Shinya Sakuma博士说:“微流控芯片拥有十字形分拣区和有三个分支的微流控通道。主通道里的靶体/非靶体细胞在三个维度上对齐。当检测到靶细胞时,片上泵迅速启动,把细胞拣入两条兴趣通道之一。同时,把非靶细胞冲入废料通道,泵不发动。
Related Links:
名古屋大学
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing
Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more
UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care
Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more
Noninvasive AI-Enabled Raman Probe Distinguishes Skin Cancers from Normal Tissue
Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas.... Read more
Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders
Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read moreMolecular Diagnostics
view channel
Blood-Based MRD Test Shows High Specificity in Colorectal Cancer Trials
Patients with stage II and III colorectal cancer may require monitoring for residual or recurrent disease after treatment. Circulating tumor DNA (ctDNA) testing offers a blood-based way to detect remaining... Read more
Facilitated Cascade Program Increases Genetic Testing in Hereditary Cancer Families
Hereditary cancer risk can extend beyond an individual patient to parents, siblings, and children. Although BRCA1 and BRCA2 mutations are linked to elevated risks of breast, ovarian, prostate, and other... Read moreHematology
view channel
New Donor Genetic Marker May Help Predict Stem Cell Transplant Success
Donor selection for hematopoietic stem cell transplantation plays a major role in relapse risk and survival for patients with blood cancers and other blood disorders. Despite advances in genotyping, uncertainty... Read more
Updated Ferritin Thresholds Improve Detection of Iron Deficiency
Iron deficiency is one of the most common health conditions worldwide, yet its nonspecific symptoms can delay diagnosis for months. Variation in testing practices and ferritin thresholds may contribute... Read moreImmunology
view channel
New Web-Based Platform Helps Autoimmune Laboratories Manage Testing Complexity
Autoimmune disease testing often requires laboratories to coordinate results across multiple instruments, manual microscopy, and patient histories. As testing volumes and workflow complexity increase,... Read more
Routine Newborn Blood Spots Can Measure GBS Antibody Levels
Group B Streptococcus (GBS) can cause serious infections in newborns. Protecting infants remains challenging because immune protection may depend on antibodies transferred from mother to baby before birth.... Read moreMicrobiology
view channel
Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification
Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more
Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive
Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more
FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample
Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more
One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens
Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read morePathology
view channel
Rapid Mass Spectrometry Test May Aid Glioma Margin Decisions
Glioma brain tumors are highly infiltrative and can extend into nearby healthy brain tissue, making tumor margins difficult to define during surgery. Residual tumor cells may contribute to recurrence and... Read more
Genomic Classifier Predicts Benefit From Adding Hormone Therapy to Salvage Prostate Radiation
Men who have undergone prostatectomy for prostate cancer may later develop a detectable or rising prostate-specific antigen, prompting salvage radiation therapy. A key challenge is determining who is most... Read moreTechnology
view channelLaser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read moreIndustry
view channel
Collaboration Advances Automated Benchtop Platform for Routine Blood Testing
Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Expanded Partnership Supports AI Biomarker Validation and Clinical Trial Deployment
CellCarta (Montreal, Canada) and Imagene AI (Miami, FL, USA) have expanded their collaboration to provide biopharma companies with a coordinated pathway for biomarker strategy, assay development, validation,... Read more
Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection
Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more







